CEPHALEXIN (cephalexin) by Inpharmus is 12. Approved for the following infections caused by susceptible isolates of designated bacteria: respiratory tract infection ( ) otitis media ( ) skin, skin structure infections ( ) bone infections ( ) genitourinary tract infections ( ) to reduce the development of drug-resistant bacteria, maintain the effectiveness of cephalexin for oral suspension and 18 more indications. First approved in 2007.
Drug data last refreshed 21h ago
12.1 Mechanism of Action Cephalexin is a cephalosporin antibacterial drug [see Microbiology ( )] . 12.3 Pharmacokinetics Absorption: Cephalexin is acid stable and may be given without regard to meals. Following doses of 250 mg, 500 mg, and 1 g, average peak serum levels of approximately 9, 18, and…
Worked on CEPHALEXIN at Inpharmus? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Oral Amoxicillin and Cephalexin PK/PD in Neonates
Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections
A Study of Cephalexin Liquid in Healthy Participants
A Study of Cephalexin Liquid for Pediatrics in Healthy Adults Participants
A Study of Cephalexin Suspension in Healthy Participants